Contract 36C26122F0032
Alba Bioscience, Inc. · Department Of Veterans Affairs · June 25, 2024
Alba Bioscience, Inc. was awarded a federal contract by Department Of Veterans Affairs on June 25, 2024 for $39,000 of work in in-vitro diagnostic substance manufacturing. Performance is in San Francisco, CA. This is a task or delivery order issued under parent IDIQ 36F79721D0259. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 12, 2026. If all options are exercised, the contract could reach $98,000.
Contract details
- PIID
- 36C26122F0032
- Parent IDIQ
- 36F79721D0259
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- San Francisco, CA
- First action
- June 25, 2024
- Latest action
- February 12, 2026
Description
BLOOD TUBE TESTING REAGENTS DEOB
Modification timeline
-
February 12, 2026Mod P00010 · Funding Only Action$76.7K
-
October 1, 2025Mod P00009 · Exercise An OptionBLOOD TUBE TESTING REAGENTS OY4$85.2K
-
October 1, 2025Mod P00009$23.6K
-
June 25, 2024Mod P00005 · Other Administrative ActionBLOOD TUBE TESTING REAGENTS ADMIN MOD$47.7K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Biomerieux Inc | Department Of Veterans Affairs | July 2, 2026 | $845.5K |
| Abbott Laboratories Inc. | Department Of Veterans Affairs | July 2, 2026 | $11.0K |
| Tosoh Bioscience, Inc. | Department Of Veterans Affairs | July 2, 2026 | $1.2K |
| Tosoh Bioscience, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Abbott Molecular Inc. | Department Of Veterans Affairs | July 1, 2026 | $729.8K |
| Cepheid | Department Of Veterans Affairs | July 1, 2026 | $305.8K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26122F0032?
Contract 36C26122F0032 is a federal contract awarded to Alba Bioscience, Inc. by Department Of Veterans Affairs on June 25, 2024 for $39,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 36C26122F0032?
Alba Bioscience, Inc. won contract 36C26122F0032 from Department Of Veterans Affairs.
How much is contract 36C26122F0032 worth?
Contract 36C26122F0032 has obligated $39,000 to date, with a total potential value of $98,000 if all options are exercised.